Stockscreener 앱 받기
22.95
3.53%
-0.825
시간 외 거래:
22.98
0.025
+0.11%
전일 마감가:
$23.78
열려 있는:
$23.29
하루 거래량:
560.05K
Relative Volume:
0.70
시가총액:
$1.39B
수익:
$688.00K
순이익/손실:
$-170.19M
주가수익비율:
-7.5275
EPS:
-3.0495
순현금흐름:
$-154.68M
1주 성능:
-6.90%
1개월 성능:
+44.37%
6개월 성능:
+51.82%
1년 성능:
-34.70%
1일 변동 폭
$22.87
$23.56
1주일 범위
$22.42
$25.00
52주 변동 폭
$10.91
$40.26
Spyre Therapeutics Inc Stock (SYRE) Company Profile
명칭
Spyre Therapeutics Inc
전화
(617) 651-5940
주소
221 CRESCENT STREET, WALTHAM
SYRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SYRE
Spyre Therapeutics Inc
|
22.95 | 1.84B | 688.00K | -170.19M | -154.68M | -3.0495 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.33 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.97 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.26 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.34 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.74 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-26 | 개시 | Deutsche Bank | Buy |
| 2025-04-08 | 개시 | Leerink Partners | Outperform |
| 2025-03-18 | 개시 | Wolfe Research | Outperform |
| 2024-09-04 | 개시 | Wedbush | Outperform |
| 2024-07-16 | 개시 | Evercore ISI | Outperform |
| 2024-05-02 | 개시 | Robert W. Baird | Outperform |
| 2024-03-01 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-12-20 | 개시 | BTIG Research | Buy |
| 2023-12-11 | 개시 | Guggenheim | Buy |
| 2023-12-11 | 개시 | Jefferies | Buy |
| 2020-05-04 | 개시 | Piper Sandler | Overweight |
| 2019-03-21 | 개시 | JP Morgan | Overweight |
| 2018-09-04 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2018-04-24 | 개시 | Evercore ISI | Outperform |
| 2018-03-14 | 재확인 | Needham | Buy |
모두보기
Spyre Therapeutics Inc 주식(SYRE)의 최신 뉴스
Will Spyre Therapeutics Inc. stock recover faster than peers2025 Retail Activity & Stock Market Timing Techniques - newser.com
Will Spyre Therapeutics Inc. (3920) stock see insider accumulationEarnings Miss & AI Driven Stock Price Forecasts - newser.com
Published on: 2025-11-04 03:55:19 - newser.com
Why Spyre Therapeutics Inc. stock is seen as undervaluedPortfolio Gains Summary & Breakout Confirmation Alerts - newser.com
Can a trend reversal in Spyre Therapeutics Inc. lead to recoveryTrade Exit Report & Consistent Profit Alerts - newser.com
What margin trends mean for Spyre Therapeutics Inc. stockLong Setup & Fast Gain Swing Trade Alerts - newser.com
Is Spyre Therapeutics Inc. (3920) stock inflation resilientEarnings Trend Report & Verified Technical Trade Signals - newser.com
Using data tools to time your Spyre Therapeutics Inc. exitPortfolio Profit Report & Precise Swing Trade Alerts - newser.com
Will Spyre Therapeutics Inc. stock sustain high P E ratios2025 Macro Impact & Low Drawdown Investment Strategies - newser.com
Is Spyre Therapeutics Inc. (3920) stock at risk of policy regulationJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - newser.com
What sentiment indicators say about Spyre Therapeutics Inc. stockJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - newser.com
Why retail investors favor Spyre Therapeutics Inc. stock2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com
Is Spyre Therapeutics Inc. stock a buy for dividend growth2025 Big Picture & Free High Return Stock Watch Alerts - newser.com
Is a relief rally coming for Spyre Therapeutics Inc. holdersJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
What insider purchases suggest about Spyre Therapeutics Inc. (3920) stockMarket Movers & AI Driven Stock Reports - newser.com
What dividend safety score for Spyre Therapeutics Inc. stockChart Signals & Free Accurate Trade Setup Notifications - newser.com
Can Spyre Therapeutics Inc. stock sustain free cash flow growthShare Buyback & AI Powered Market Entry Strategies - newser.com
Using Ichimoku Cloud for Spyre Therapeutics Inc. technicalsEarnings Overview Report & Weekly High Potential Stock Alerts - newser.com
Will Spyre Therapeutics Inc. (3920) stock beat international competitionMarket Risk Report & Low Risk High Win Rate Stock Picks - newser.com
Will Spyre Therapeutics Inc. stock deliver strong dividend growthJuly 2025 Highlights & Smart Swing Trading Alerts - newser.com
Will Spyre Therapeutics Inc. (3920) stock sustain uptrend momentumStop Loss & Expert Verified Movement Alerts - newser.com
Is Spyre Therapeutics Inc. (3920) stock undervalued after correction2025 Price Momentum & Consistent Growth Stock Picks - newser.com
Will Spyre Therapeutics Inc. stock maintain dividend yieldMarket Performance Summary & Weekly High Potential Alerts - newser.com
Is Spyre Therapeutics Inc. stock supported by innovation pipelineJuly 2025 Snapshot & Stock Portfolio Risk Control - newser.com
Why Spyre Therapeutics Inc. stock remains on watchlistsPortfolio Risk Report & Real-Time Market Trend Scan - newser.com
How to escape a deep drawdown in Spyre Therapeutics Inc.July 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Published on: 2025-11-02 03:35:20 - newser.com
Why Spyre Therapeutics Inc. stock remains undervalued2025 AllTime Highs & Smart Allocation Stock Tips - newser.com
Earnings visualization tools for Spyre Therapeutics Inc.July 2025 Patterns & Community Consensus Trade Alerts - newser.com
Spyre Therapeutics Inc (SYRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):